KR100768415B1 - 치환된 스티릴 벤질설폰, 이의 제조방법 및 이를 포함하는 증식성 장애 치료용 약제학적 조성물 - Google Patents

치환된 스티릴 벤질설폰, 이의 제조방법 및 이를 포함하는 증식성 장애 치료용 약제학적 조성물 Download PDF

Info

Publication number
KR100768415B1
KR100768415B1 KR1020027013708A KR20027013708A KR100768415B1 KR 100768415 B1 KR100768415 B1 KR 100768415B1 KR 1020027013708 A KR1020027013708 A KR 1020027013708A KR 20027013708 A KR20027013708 A KR 20027013708A KR 100768415 B1 KR100768415 B1 KR 100768415B1
Authority
KR
South Korea
Prior art keywords
delete delete
alkoxy
halogen
amino
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
KR1020027013708A
Other languages
English (en)
Korean (ko)
Other versions
KR20030029044A (ko
Inventor
레디이.프렘쿠머
레디엠.브이.라마나
Original Assignee
템플 유니버시티-오브 더 커먼웰쓰 시스템 오브 하이어 에듀케이션
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 템플 유니버시티-오브 더 커먼웰쓰 시스템 오브 하이어 에듀케이션 filed Critical 템플 유니버시티-오브 더 커먼웰쓰 시스템 오브 하이어 에듀케이션
Publication of KR20030029044A publication Critical patent/KR20030029044A/ko
Application granted granted Critical
Publication of KR100768415B1 publication Critical patent/KR100768415B1/ko
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/52—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/02—Sulfones; Sulfoxides having sulfone or sulfoxide groups bound to acyclic carbon atoms
    • C07C317/10—Sulfones; Sulfoxides having sulfone or sulfoxide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/16—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C317/18—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton with sulfone or sulfoxide groups bound to acyclic carbon atoms of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/60—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton with the carbon atom of at least one of the carboxyl groups bound to nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/12—Esters of phosphoric acids with hydroxyaryl compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Reproductive Health (AREA)
  • Molecular Biology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
KR1020027013708A 2000-04-14 2001-04-13 치환된 스티릴 벤질설폰, 이의 제조방법 및 이를 포함하는 증식성 장애 치료용 약제학적 조성물 Expired - Lifetime KR100768415B1 (ko)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US19784900P 2000-04-14 2000-04-14
US60/197,849 2000-04-14
US23470700P 2000-09-22 2000-09-22
US60/234,707 2000-09-22
US27164001P 2001-02-27 2001-02-27
US60/271,640 2001-02-27
PCT/US2001/012134 WO2001078712A1 (en) 2000-04-14 2001-04-13 Substituted styryl benzylsulfones for treating proliferative disorders

Publications (2)

Publication Number Publication Date
KR20030029044A KR20030029044A (ko) 2003-04-11
KR100768415B1 true KR100768415B1 (ko) 2007-10-18

Family

ID=27393791

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020027013708A Expired - Lifetime KR100768415B1 (ko) 2000-04-14 2001-04-13 치환된 스티릴 벤질설폰, 이의 제조방법 및 이를 포함하는 증식성 장애 치료용 약제학적 조성물

Country Status (13)

Country Link
US (2) US6486210B2 (enExample)
EP (2) EP2359819A1 (enExample)
JP (1) JP4677162B2 (enExample)
KR (1) KR100768415B1 (enExample)
AU (2) AU2001251615C1 (enExample)
CA (1) CA2406212C (enExample)
DK (1) DK1305015T3 (enExample)
ES (1) ES2427088T3 (enExample)
IL (2) IL152190A0 (enExample)
NZ (1) NZ522551A (enExample)
PT (1) PT1305015E (enExample)
SI (1) SI1305015T1 (enExample)
WO (1) WO2001078712A1 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6762207B1 (en) * 1999-04-02 2004-07-13 Temple University - Of The Commonwealth System Of Higher Education (E)-styryl sulfone anticancer agents
US7053123B2 (en) 2000-10-05 2006-05-30 Temple University-Of The Commonwealth System Of Higher Education Substituted (e)-styryl benzylsulfones for treating proliferative disorders
JP2004521126A (ja) * 2001-02-27 2004-07-15 テンプル・ユニバーシティ−オブ・ザ・コモンウェルス・システム・オブ・ハイアー・エデュケイション （ｚ）−スチリルベンジルスルホン及びそれらの医薬としての使用
EP1370253B8 (en) 2001-02-28 2008-11-26 Temple University of the Commonwealth System of Higher Education Use of alpha, beta unsaturated aryl sulfones for protecting cells and tissues from ionizing radiation toxicity
US7161031B2 (en) * 2002-02-28 2007-01-09 Temple University - Of The Commonwealth System Of Higher Education Amino-substituted sulfonanilides and derivatives thereof for treating proliferative disorders
WO2003072062A2 (en) * 2002-02-28 2003-09-04 Temple University-Of The Commonwealth System Of Higher Education Amino-substituted (e)-2,6-dialkoxystyryl 4-substituted benzylsulfones for treating proliferative disorders
JP4182844B2 (ja) * 2003-09-03 2008-11-19 株式会社島津製作所 質量分析装置
AU2004289281C1 (en) * 2003-11-14 2011-12-08 Onconova Therapeutics, Inc. Alpha, beta-Unsaturated sulfoxides for treating proliferative disorders
EP3138832A1 (en) 2004-03-16 2017-03-08 Temple University - Of The Commonwealth System of Higher Education Substituted phenoxy- and phenylthio- derivatives for treating proliferative disorders
US8058313B2 (en) 2004-06-24 2011-11-15 Temple University—Of the Commonwealth System of Higher Education Alpha, beta-unsaturated sulfones, sulfoxides, sulfonimides, sulfinimides, acylsulfonamides and acylsulfinamides and therapeutic uses thereof
US20090306207A1 (en) * 2005-01-05 2009-12-10 Reddy M V Ramana Treatment of Drug-Resistant Proliferative Disorders
SI1896401T1 (sl) * 2005-02-25 2013-07-31 Temple University - Of The Commonwealth System Of Higher Education Sinteza nenasičenih sulfidov, sulfonov, sulfoksidov in sulfonamidov
WO2006104668A2 (en) * 2005-03-11 2006-10-05 Temple University - Of The Commonwealth System Of Higher Education Composition and methods for the treatment of proliferative diseases
WO2008027049A1 (en) * 2006-08-30 2008-03-06 Temple University - Of The Commonwealth System Of Higher Education Composition and methods for the treatment of myelodysplastic syndrome and acute myeloid leukemia
WO2008033475A2 (en) * 2006-09-15 2008-03-20 Onconova Therapeutics, Inc. Activated cytotoxic compounds for attachment to targeting molecules for the treatment of mammalian disease conditions
US8735620B2 (en) * 2008-12-17 2014-05-27 Epr Pharmaceuticals Pvt. Ltd Processes for preparing (E)-styrylbenzylsulfone compounds and uses thereof for treating proliferative disorders
AU2013318206B2 (en) 2012-09-20 2018-07-26 Temple University - Of The Commonwealth System Of Higher Education Substituted alkyl diaryl derivatives, methods of preparation and uses
ES2864681T3 (es) 2012-12-07 2021-10-14 Onconova Therapeutics Inc Tratamiento del cáncer hematológico refractario a un agente contra el cáncer
US10383831B2 (en) 2015-08-03 2019-08-20 Temple University—Of the Commonwealth System of Higher Education 2,4,6-trialkoxystryl aryl sulfones, sulfonamides and carboxamides, and methods of preparation and use
WO2024186641A1 (en) * 2023-03-03 2024-09-12 Onconova Therapeutics, Inc. Methods and compositions for treating cancer

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63150237A (ja) * 1986-11-28 1988-06-22 オリオン‐ユヒチュメ・オユ カテコール誘導体
WO1999018068A1 (en) 1997-10-03 1999-04-15 Temple University - Of The Commonwealth System Of Higher Education Styryl sulfone anticancer agents

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2532612A (en) 1945-08-29 1950-12-05 Union Oil Co Preparation of unsaturated thio-ethers
US3185743A (en) 1960-08-24 1965-05-25 Union Carbide Corp Production of olefinic compounds from allyl sulfones
US3418101A (en) 1965-12-15 1968-12-24 Pennsalt Chemicals Corp Process for plant desiccation
US3514386A (en) 1967-12-11 1970-05-26 Exxon Research Engineering Co Stereoselective addition of thiols to acetylenic compounds
US3917714A (en) 1972-09-06 1975-11-04 American Cyanamid Co Bis(alkylsulfonyl)vinylbenzenes
US4161407A (en) 1977-10-06 1979-07-17 Eastman Kodak Company Crosslinkable polymers having vinylsulfonyl groups or styrylsulfonyl groups and their use as hardeners for gelatin
US4386221A (en) 1981-10-28 1983-05-31 Eastman Kodak Company Process for the preparation of aryl alkyl sulfones and aryl vinyl sulfones
US4937388A (en) 1985-08-09 1990-06-26 Imperial Chemical Industries Plc Insecticidal ethers
FR2621038B1 (fr) * 1987-09-28 1989-12-29 Rhone Poulenc Sante Derives d'alcadienes, leurs preparations, les medicaments les contenant et produits intermediaires
GB8902409D0 (en) * 1989-02-03 1989-03-22 Ici Plc Aliphatic compounds
US5659087A (en) 1995-06-07 1997-08-19 Eli Lilly And Company Diarylvinyl sulfoxides
JP3660395B2 (ja) * 1995-06-22 2005-06-15 大鵬薬品工業株式会社 フェニルスルホン誘導体及びその製造方法
BR9611232A (pt) * 1995-10-19 2000-03-28 Ciba Sc Holding Ag Antioxidantes contendo grupos fenol e grupos de anima aromática
US6201154B1 (en) * 1999-03-31 2001-03-13 Temple University-Of The Commonwealth Of Higher Education Z-styryl sulfone anticancer agents
CA2366750C (en) * 1999-04-02 2010-06-01 Temple University - Of The Commonwealth System Of Higher Education (e)-styryl sulfone anticancer agents
JP2002541101A (ja) * 1999-04-02 2002-12-03 テンプル・ユニバーシティ−オブ・ザ・コモンウェルス・システム・オブ・ハイアー・エデュケイション スチリルスルホン抗癌剤
WO2001026645A1 (en) * 1999-10-12 2001-04-19 Temple University-Of The Commonwealth System Of Higher Education Method for protecting normal cells from cytotoxicity of chemotherapeutic agents

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63150237A (ja) * 1986-11-28 1988-06-22 オリオン‐ユヒチュメ・オユ カテコール誘導体
JP2735834B2 (ja) * 1986-11-28 1998-04-02 オリオン‐ユヒチュメ・オユ カテコール誘導体
WO1999018068A1 (en) 1997-10-03 1999-04-15 Temple University - Of The Commonwealth System Of Higher Education Styryl sulfone anticancer agents

Also Published As

Publication number Publication date
EP1305015A4 (en) 2003-05-21
US20030036536A1 (en) 2003-02-20
IL152190A (en) 2010-11-30
JP4677162B2 (ja) 2011-04-27
NZ522551A (en) 2004-03-26
US6486210B2 (en) 2002-11-26
AU2001251615C1 (en) 2006-12-07
AU2001251615B2 (en) 2005-08-11
DK1305015T3 (da) 2013-08-26
ES2427088T3 (es) 2013-10-28
EP1305015A1 (en) 2003-05-02
AU5161501A (en) 2001-10-30
IL152190A0 (en) 2003-05-29
EP1305015B1 (en) 2013-06-12
JP2003530433A (ja) 2003-10-14
PT1305015E (pt) 2013-09-06
US6642410B2 (en) 2003-11-04
WO2001078712A1 (en) 2001-10-25
US20020115643A1 (en) 2002-08-22
CA2406212A1 (en) 2001-10-25
SI1305015T1 (sl) 2013-08-30
KR20030029044A (ko) 2003-04-11
EP2359819A1 (en) 2011-08-24
CA2406212C (en) 2011-02-01

Similar Documents

Publication Publication Date Title
KR100768415B1 (ko) 치환된 스티릴 벤질설폰, 이의 제조방법 및 이를 포함하는 증식성 장애 치료용 약제학적 조성물
AU2001251615A1 (en) Substituted styryl benzylsulfones for treating proliferative disorders
JP4468593B2 (ja) Ｚ−スチリルスルホン抗癌剤
US6762207B1 (en) (E)-styryl sulfone anticancer agents
KR100828449B1 (ko) 증식성 질환 치료용 α, β-불포화 설폰
AU2001251614A1 (en) Alpha,beta-unsaturated sulfones for treating proliferative disorders
EP1173160B1 (en) (e)-styryl sulfone anticancer agents
CA2424884C (en) Substituted (e)-styryl benzylsulfones for treating proliferative disorders

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20021011

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20060412

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20070129

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20070723

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20071012

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20071015

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
G170 Re-publication after modification of scope of protection [patent]
PG1701 Publication of correction
PR1001 Payment of annual fee

Payment date: 20100930

Start annual number: 4

End annual number: 4

PR1001 Payment of annual fee

Payment date: 20110928

Start annual number: 5

End annual number: 5

FPAY Annual fee payment

Payment date: 20120925

Year of fee payment: 6

PR1001 Payment of annual fee

Payment date: 20120925

Start annual number: 6

End annual number: 6

FPAY Annual fee payment

Payment date: 20130927

Year of fee payment: 7

PR1001 Payment of annual fee

Payment date: 20130927

Start annual number: 7

End annual number: 7

FPAY Annual fee payment

Payment date: 20141002

Year of fee payment: 8

PR1001 Payment of annual fee

Payment date: 20141002

Start annual number: 8

End annual number: 8

FPAY Annual fee payment

Payment date: 20150924

Year of fee payment: 9

PR1001 Payment of annual fee

Payment date: 20150924

Start annual number: 9

End annual number: 9

FPAY Annual fee payment

Payment date: 20160927

Year of fee payment: 10

PR1001 Payment of annual fee

Payment date: 20160927

Start annual number: 10

End annual number: 10

FPAY Annual fee payment

Payment date: 20181001

Year of fee payment: 12

PR1001 Payment of annual fee

Payment date: 20181001

Start annual number: 12

End annual number: 12

FPAY Annual fee payment

Payment date: 20190927

Year of fee payment: 13

PR1001 Payment of annual fee

Payment date: 20190927

Start annual number: 13

End annual number: 13

PC1801 Expiration of term

Termination date: 20211013

Termination category: Expiration of duration